KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Enterprise Value (2018 - 2025)

Progyny (PGNY) has disclosed Enterprise Value for 8 consecutive years, with -$310.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value changed N/A to -$310.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$310.1 million, a N/A change, with the full-year FY2025 number at -$310.1 million, changed N/A from a year prior.
  • Enterprise Value was -$310.1 million for Q4 2025 at Progyny, up from -$345.2 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$94.0 million in Q2 2021 to a low of -$371.8 million in Q1 2024.
  • A 5-year average of -$225.1 million and a median of -$235.7 million in 2024 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: crashed 137.99% in 2023, then surged 31.12% in 2025.
  • Progyny's Enterprise Value stood at -$119.4 million in 2021, then tumbled by 58.52% to -$189.3 million in 2022, then plummeted by 96.03% to -$371.1 million in 2023, then soared by 36.48% to -$235.7 million in 2024, then tumbled by 31.55% to -$310.1 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Enterprise Value are -$310.1 million (Q4 2025), -$345.2 million (Q3 2025), and -$305.1 million (Q2 2025).